Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript
Operator: Good day, everyone, and thank you for standing by. My name is RG, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 172,245 | $1,359,016 | +24% | 0% |
| 2. | 43,500 | $343,215 | -27% | 0% | |
| 3. | Lion Point Didric Cederholm | 31,570 | $249,087 | 1.19% | |
| 4. | Citadel Investment Group Ken Griffin | 10,504 | $82,877 | 0% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | $18,350,309.25 | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | $9,175,156.20 | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.55 | 64 | $291.20 | 8,679 | 2026-08-17 | Filing | |
| $4.55 | 263 | $1,196.65 | 12,499 | 2026-08-17 | Filing | |
| $4.55 | 81 | $368.55 | 7,995 | 2026-08-17 | Filing | |
| $4.55 | 82 | $373.10 | 8,117 | 2026-08-17 | Filing | |
| $7.53 | 259 | $1,950.27 | 12,040 | 2026-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,155,850 | $9,119,658 | 0.59% | |
| 2. | 287,776 | $2,270,553 | 0% | |
| 3. | 122,975 | $970,273 | 0% | |
| 4. | 111,000 | $875,790 | 0% | |
| 5. | 79,974 | $631,301 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Seres Therapeutics Second Quarter 2025 Results and Business Update Call. [Operator Instructions] Please note, this call is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
On March 12, the Nasdaq Composite Index was up by 1.5%, spearheaded by the technology stocks that have been leading the tech-heavy index ever higher for a long time now.
11 Oversold Healthcare Stocks To Buy Right Now
The healthcare sector has been popular among investors for some time now, but it is starting to become the new "2024 idea" for investing portfolios because of its performance so far.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Hedge Fund Resource Center